BioBusiness

Current Issue

ADVERTISEMENT

ADVERTISEMENT

Follow GEN on Twitter
GENdex
Markets
Stocks
Mutual Funds & ETF's
Sectors
Rates
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
PDL BIOPHARMA (NQ: PDLI)
-0.0100 (-0.1605%)
at
6.220 USD
1,272,757 in Volume
Add to:
My Watchlist
Data as of 08:10 PM EDT Jul 30, 2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Today's Open 6.180
Bid (Size) 6.220 (19100)
Ask (Size) 6.230 (29900)
Prev. Close 6.230
Today's Range 6.100 - 6.290
52wk Range 5.030 - 9.320
Shares Outstanding 119,674,377
Morningstar Profile
View Full Profile
PDL BIOPHARMA
The Company is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.
Healthcare
Biotechnology
Exchange Traded NQ
Market Cap 744.37M
Related Companies INRLF TRGNF 0MKD FACT
Top News
Read More
PDL BioPharma to Present at BMO Capital Markets' 10th Annual Focus on Healthcare Conference
Jul 29, 2010
from PRNewsWire News Releases
PDL BioPharma, Inc. Q2 2010 Earnings Call Transcript   
Jul 28, 2010
PDL BioPharma, Inc. ( PDLI ) Q2 2010 Earnings Call July 28, 2010 16:30 am ET Complete Story »  Read More
from Transcripts from Seeking Alpha
More News
Read More
PDL BioPharma, Inc. Q2 2010 Earnings Call Transcript   
Jul 28, 2010
category Earnings , PDLI , Finance , and 8 more.
from BNET.com
PDL BioPharma (PDLI) Reports Q2 EPS of $0.30, Misses by 8c   
Jul 28, 2010
from StreetInsider.com News Articles
PDL BioPharma reports Q2 EPS 30c vs. consensus of 38c   
Jul 28, 2010
category Earnings
from theflyonthewall.com
PDL BioPharma Announces Second Quarter 2010 Financial Results
Jul 28, 2010
from PRNewsWire News Releases
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
Bots go here